Management of lower urinary tract symptoms in men with progressive neurological disease

PURPOSE OF REVIEWProgressive neurological disease can cause lower urinary tract symptoms similar to those seen in bladder outflow obstruction. Increasingly common with age, these two groups of conditions often coexist. The complex pathophysiology of men with this combination of problems is often poo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Current opinion in urology 2006-01, Vol.16 (1), p.30-36
Hauptverfasser: Woderich, René, Fowler, Clare J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 36
container_issue 1
container_start_page 30
container_title Current opinion in urology
container_volume 16
creator Woderich, René
Fowler, Clare J
description PURPOSE OF REVIEWProgressive neurological disease can cause lower urinary tract symptoms similar to those seen in bladder outflow obstruction. Increasingly common with age, these two groups of conditions often coexist. The complex pathophysiology of men with this combination of problems is often poorly understood and suboptimally managed, mostly with long-term indwelling catheters. This review looks at recent diagnostic advances and emerging therapeutic alternatives. RECENT FINDINGSFor various neurogenic bladder disorders, urodynamic studies may demonstrate typical constellations of abnormalities, but no pathognomonic features. Other modalities such as sphincter electromyography and central nervous system imaging have been proposed to aid diagnosis. Functional brain imaging has helped to understand the complex nature of bladder storage and micturition control. A new generation of bladder-selective antimuscarinics has graduated through phase-III randomized controlled trials and these are now available for routine use. These agents are as efficacious as oxybutynin but have better side-effect profiles. Modern minimally invasive techniques such as desensitizing bladder instillations or injections of botulinum toxin have safely been used and are achieving excellent results. SUMMARYUrodynamic studies are important and increasingly regarded as mandatory in all men considered for outflow surgery. Neurogenic bladder and sphincter dysfunction can be managed conservatively or with new minimally invasive techniques. Surgery should be reserved for severely symptomatic treatment failures. A working knowledge of common neurological disease associated with lower urinary tract dysfunction is important for urologists to diagnose these conditions or initiate an appropriate referral. This article gives an overview of recent work that has implications for the diagnosis and management of neurological disorders of micturition.
doi_str_mv 10.1097/01.mou.0000193370.76576.57
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67600358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67600358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3627-8ef8ea9eda58bb3f2519b097f27d7ec8e9ef44880392ba8cf77d0849f83690963</originalsourceid><addsrcrecordid>eNpFkEtP3DAURi3UCobHX0AWi-6SXseJH-wqBBSJik2rLi0nuZ5J68RTO2HEv8fTGQlvriyd-_gOITcMSgZafgVWjmEpIT-mOZdQStFIUTbyhKxYLXkhGiU-kRVowQsQNT8j5yn9yXilGT8lZ0xw1TCtVuT3DzvZNY44zTQ46sMOI13iMNn4Rudou5mmt3E7hzHRYaKZo7th3tBtDOuIKQ2vSCdcYvBhPXTW035IaBNeks_O-oRXx3pBfj3c_7z7Xjy_PD7dfXsuOi4qWSh0Cq3G3jaqbbmr8lVtzugq2UvsFGp0da0UcF21VnVOyh5UrZ3iQu_jXZAvh7n5oH8LptmMQ-rQezthWJIRUgDwRmXw9gB2MaQU0ZltHMac0jAwe60GmMlazYdW81-raWRuvj5uWdoR-4_Wo8cM1AdgF_yMMf31SxZpNmj9vNmPrCsOsqgABLD8LfZbJH8HHeKFxg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67600358</pqid></control><display><type>article</type><title>Management of lower urinary tract symptoms in men with progressive neurological disease</title><source>MEDLINE</source><source>Journals@Ovid Ovid Autoload</source><creator>Woderich, René ; Fowler, Clare J</creator><creatorcontrib>Woderich, René ; Fowler, Clare J</creatorcontrib><description>PURPOSE OF REVIEWProgressive neurological disease can cause lower urinary tract symptoms similar to those seen in bladder outflow obstruction. Increasingly common with age, these two groups of conditions often coexist. The complex pathophysiology of men with this combination of problems is often poorly understood and suboptimally managed, mostly with long-term indwelling catheters. This review looks at recent diagnostic advances and emerging therapeutic alternatives. RECENT FINDINGSFor various neurogenic bladder disorders, urodynamic studies may demonstrate typical constellations of abnormalities, but no pathognomonic features. Other modalities such as sphincter electromyography and central nervous system imaging have been proposed to aid diagnosis. Functional brain imaging has helped to understand the complex nature of bladder storage and micturition control. A new generation of bladder-selective antimuscarinics has graduated through phase-III randomized controlled trials and these are now available for routine use. These agents are as efficacious as oxybutynin but have better side-effect profiles. Modern minimally invasive techniques such as desensitizing bladder instillations or injections of botulinum toxin have safely been used and are achieving excellent results. SUMMARYUrodynamic studies are important and increasingly regarded as mandatory in all men considered for outflow surgery. Neurogenic bladder and sphincter dysfunction can be managed conservatively or with new minimally invasive techniques. Surgery should be reserved for severely symptomatic treatment failures. A working knowledge of common neurological disease associated with lower urinary tract dysfunction is important for urologists to diagnose these conditions or initiate an appropriate referral. This article gives an overview of recent work that has implications for the diagnosis and management of neurological disorders of micturition.</description><identifier>ISSN: 0963-0643</identifier><identifier>EISSN: 1473-6586</identifier><identifier>DOI: 10.1097/01.mou.0000193370.76576.57</identifier><identifier>PMID: 16385198</identifier><language>eng</language><publisher>United States: Lippincott Williams &amp; Wilkins, Inc</publisher><subject>Administration, Intravesical ; Diagnostic Imaging ; Disease Progression ; Electromyography ; Humans ; Male ; Muscarinic Antagonists - administration &amp; dosage ; Muscarinic Antagonists - therapeutic use ; Nervous System Diseases - complications ; Randomized Controlled Trials as Topic ; Urinary Bladder, Neurogenic - diagnosis ; Urinary Bladder, Neurogenic - physiopathology ; Urinary Bladder, Neurogenic - therapy ; Urodynamics</subject><ispartof>Current opinion in urology, 2006-01, Vol.16 (1), p.30-36</ispartof><rights>2006 Lippincott Williams &amp; Wilkins, Inc.</rights><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3627-8ef8ea9eda58bb3f2519b097f27d7ec8e9ef44880392ba8cf77d0849f83690963</citedby><cites>FETCH-LOGICAL-c3627-8ef8ea9eda58bb3f2519b097f27d7ec8e9ef44880392ba8cf77d0849f83690963</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16385198$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Woderich, René</creatorcontrib><creatorcontrib>Fowler, Clare J</creatorcontrib><title>Management of lower urinary tract symptoms in men with progressive neurological disease</title><title>Current opinion in urology</title><addtitle>Curr Opin Urol</addtitle><description>PURPOSE OF REVIEWProgressive neurological disease can cause lower urinary tract symptoms similar to those seen in bladder outflow obstruction. Increasingly common with age, these two groups of conditions often coexist. The complex pathophysiology of men with this combination of problems is often poorly understood and suboptimally managed, mostly with long-term indwelling catheters. This review looks at recent diagnostic advances and emerging therapeutic alternatives. RECENT FINDINGSFor various neurogenic bladder disorders, urodynamic studies may demonstrate typical constellations of abnormalities, but no pathognomonic features. Other modalities such as sphincter electromyography and central nervous system imaging have been proposed to aid diagnosis. Functional brain imaging has helped to understand the complex nature of bladder storage and micturition control. A new generation of bladder-selective antimuscarinics has graduated through phase-III randomized controlled trials and these are now available for routine use. These agents are as efficacious as oxybutynin but have better side-effect profiles. Modern minimally invasive techniques such as desensitizing bladder instillations or injections of botulinum toxin have safely been used and are achieving excellent results. SUMMARYUrodynamic studies are important and increasingly regarded as mandatory in all men considered for outflow surgery. Neurogenic bladder and sphincter dysfunction can be managed conservatively or with new minimally invasive techniques. Surgery should be reserved for severely symptomatic treatment failures. A working knowledge of common neurological disease associated with lower urinary tract dysfunction is important for urologists to diagnose these conditions or initiate an appropriate referral. This article gives an overview of recent work that has implications for the diagnosis and management of neurological disorders of micturition.</description><subject>Administration, Intravesical</subject><subject>Diagnostic Imaging</subject><subject>Disease Progression</subject><subject>Electromyography</subject><subject>Humans</subject><subject>Male</subject><subject>Muscarinic Antagonists - administration &amp; dosage</subject><subject>Muscarinic Antagonists - therapeutic use</subject><subject>Nervous System Diseases - complications</subject><subject>Randomized Controlled Trials as Topic</subject><subject>Urinary Bladder, Neurogenic - diagnosis</subject><subject>Urinary Bladder, Neurogenic - physiopathology</subject><subject>Urinary Bladder, Neurogenic - therapy</subject><subject>Urodynamics</subject><issn>0963-0643</issn><issn>1473-6586</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkEtP3DAURi3UCobHX0AWi-6SXseJH-wqBBSJik2rLi0nuZ5J68RTO2HEv8fTGQlvriyd-_gOITcMSgZafgVWjmEpIT-mOZdQStFIUTbyhKxYLXkhGiU-kRVowQsQNT8j5yn9yXilGT8lZ0xw1TCtVuT3DzvZNY44zTQ46sMOI13iMNn4Rudou5mmt3E7hzHRYaKZo7th3tBtDOuIKQ2vSCdcYvBhPXTW035IaBNeks_O-oRXx3pBfj3c_7z7Xjy_PD7dfXsuOi4qWSh0Cq3G3jaqbbmr8lVtzugq2UvsFGp0da0UcF21VnVOyh5UrZ3iQu_jXZAvh7n5oH8LptmMQ-rQezthWJIRUgDwRmXw9gB2MaQU0ZltHMac0jAwe60GmMlazYdW81-raWRuvj5uWdoR-4_Wo8cM1AdgF_yMMf31SxZpNmj9vNmPrCsOsqgABLD8LfZbJH8HHeKFxg</recordid><startdate>200601</startdate><enddate>200601</enddate><creator>Woderich, René</creator><creator>Fowler, Clare J</creator><general>Lippincott Williams &amp; Wilkins, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200601</creationdate><title>Management of lower urinary tract symptoms in men with progressive neurological disease</title><author>Woderich, René ; Fowler, Clare J</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3627-8ef8ea9eda58bb3f2519b097f27d7ec8e9ef44880392ba8cf77d0849f83690963</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Administration, Intravesical</topic><topic>Diagnostic Imaging</topic><topic>Disease Progression</topic><topic>Electromyography</topic><topic>Humans</topic><topic>Male</topic><topic>Muscarinic Antagonists - administration &amp; dosage</topic><topic>Muscarinic Antagonists - therapeutic use</topic><topic>Nervous System Diseases - complications</topic><topic>Randomized Controlled Trials as Topic</topic><topic>Urinary Bladder, Neurogenic - diagnosis</topic><topic>Urinary Bladder, Neurogenic - physiopathology</topic><topic>Urinary Bladder, Neurogenic - therapy</topic><topic>Urodynamics</topic><toplevel>online_resources</toplevel><creatorcontrib>Woderich, René</creatorcontrib><creatorcontrib>Fowler, Clare J</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Current opinion in urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Woderich, René</au><au>Fowler, Clare J</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Management of lower urinary tract symptoms in men with progressive neurological disease</atitle><jtitle>Current opinion in urology</jtitle><addtitle>Curr Opin Urol</addtitle><date>2006-01</date><risdate>2006</risdate><volume>16</volume><issue>1</issue><spage>30</spage><epage>36</epage><pages>30-36</pages><issn>0963-0643</issn><eissn>1473-6586</eissn><abstract>PURPOSE OF REVIEWProgressive neurological disease can cause lower urinary tract symptoms similar to those seen in bladder outflow obstruction. Increasingly common with age, these two groups of conditions often coexist. The complex pathophysiology of men with this combination of problems is often poorly understood and suboptimally managed, mostly with long-term indwelling catheters. This review looks at recent diagnostic advances and emerging therapeutic alternatives. RECENT FINDINGSFor various neurogenic bladder disorders, urodynamic studies may demonstrate typical constellations of abnormalities, but no pathognomonic features. Other modalities such as sphincter electromyography and central nervous system imaging have been proposed to aid diagnosis. Functional brain imaging has helped to understand the complex nature of bladder storage and micturition control. A new generation of bladder-selective antimuscarinics has graduated through phase-III randomized controlled trials and these are now available for routine use. These agents are as efficacious as oxybutynin but have better side-effect profiles. Modern minimally invasive techniques such as desensitizing bladder instillations or injections of botulinum toxin have safely been used and are achieving excellent results. SUMMARYUrodynamic studies are important and increasingly regarded as mandatory in all men considered for outflow surgery. Neurogenic bladder and sphincter dysfunction can be managed conservatively or with new minimally invasive techniques. Surgery should be reserved for severely symptomatic treatment failures. A working knowledge of common neurological disease associated with lower urinary tract dysfunction is important for urologists to diagnose these conditions or initiate an appropriate referral. This article gives an overview of recent work that has implications for the diagnosis and management of neurological disorders of micturition.</abstract><cop>United States</cop><pub>Lippincott Williams &amp; Wilkins, Inc</pub><pmid>16385198</pmid><doi>10.1097/01.mou.0000193370.76576.57</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0963-0643
ispartof Current opinion in urology, 2006-01, Vol.16 (1), p.30-36
issn 0963-0643
1473-6586
language eng
recordid cdi_proquest_miscellaneous_67600358
source MEDLINE; Journals@Ovid Ovid Autoload
subjects Administration, Intravesical
Diagnostic Imaging
Disease Progression
Electromyography
Humans
Male
Muscarinic Antagonists - administration & dosage
Muscarinic Antagonists - therapeutic use
Nervous System Diseases - complications
Randomized Controlled Trials as Topic
Urinary Bladder, Neurogenic - diagnosis
Urinary Bladder, Neurogenic - physiopathology
Urinary Bladder, Neurogenic - therapy
Urodynamics
title Management of lower urinary tract symptoms in men with progressive neurological disease
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T17%3A04%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Management%20of%20lower%20urinary%20tract%20symptoms%20in%20men%20with%20progressive%20neurological%20disease&rft.jtitle=Current%20opinion%20in%20urology&rft.au=Woderich,%20Ren%C3%A9&rft.date=2006-01&rft.volume=16&rft.issue=1&rft.spage=30&rft.epage=36&rft.pages=30-36&rft.issn=0963-0643&rft.eissn=1473-6586&rft_id=info:doi/10.1097/01.mou.0000193370.76576.57&rft_dat=%3Cproquest_cross%3E67600358%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67600358&rft_id=info:pmid/16385198&rfr_iscdi=true